Clinical Trial Update: Study in Chronic Kidney Disease (CKD) Not on Dialysis [Phase 3]

View source ↗

Summary

A Bayer-sponsored Phase 3 trial in chronic kidney disease patients not on dialysis evaluating treatment for hyperphosphatemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Snippet

Sponsor: Bayer | Conditions: Hyperphosphatemia | Phase 3 | Status: COMPLETED